The University of Southern Mississippi

The Aquila Digital Community
Faculty Publications
1-1-2019

Vector Tick Transmission Model of Spotted Fever Rickettsiosis
Tais Berelli Saito
University of Texas Medical Branch, tbsaito@utmb.edu

Jeremy Bechelli
University of Texas Medical Branch, jrb138@shsu.edu

Claire Smalley
University of Texas Medical Branch

Shahid Karim
University of Southern Mississippi, Shahid.Karim@usm.edu

David H. Walker
University of Texas Medical Branch, dwalker@utmb.edu

Follow this and additional works at: https://aquila.usm.edu/fac_pubs
Part of the Entomology Commons

Recommended Citation
Saito, T. B., Bechelli, J., Smalley, C., Karim, S., Walker, D. H. (2019). Vector Tick Transmission Model of
Spotted Fever Rickettsiosis. The American Journal of Pathology, 189(1), 115-123.
Available at: https://aquila.usm.edu/fac_pubs/15701

This Article is brought to you for free and open access by The Aquila Digital Community. It has been accepted for
inclusion in Faculty Publications by an authorized administrator of The Aquila Digital Community. For more
information, please contact Joshua.Cromwell@usm.edu.

ACCEPTED MANUSCRIPT

Vector tick transmission model of spotted fever rickettsiosis
Tais Berelli Saito1*, Jeremy Bechelli1, Claire Smalley1, Shahid Karim2, David H. Walker1
1

Department of Pathology, University of Texas Medical Branch at Galveston, TX 77555-0609

2

RI
PT

USA
Department of Biological Sciences, University of Southern Mississippi, Hattiesburg, MS 39406

SC

USA

Footnote: Current address for J.B.: Department of Biological Sciences, Sam Houston State

Disclosures: None declared.

Number of text pages: 24

TE
D

Tables: 0

M
AN
U

University, Huntsville, TX 77341-2116, USA.

Figures: 5

EP

Short running head: Tick transmission of Rickettsia parkeri.

AC
C

Funding: Supported by The Carmage and Martha Walls Distinguished University Chair in
Tropical Diseases.

*

Corresponding author:

Tais Berelli Saito
301 University Blvd, route 0609
Galveston, TX 77555

1

ACCEPTED MANUSCRIPT

Phone: 409-772-4813
Fax: 409-772-2500

AC
C

EP

TE
D

M
AN
U

SC

RI
PT

E-mail: tbsaito@utmb.edu

2

ACCEPTED MANUSCRIPT

Abstract
Many aspects of rickettsial infections have been characterized, including pathogenic
and immune pathways, as well as mechanisms of rickettsial survival within the

RI
PT

vertebrate host and tick vector. However, there is a remarkable paucity of studies
focused on the complex pathogen-vector-host interactions during tick feeding.

Therefore, our objective was to develop a tick transmission model of spotted fever

SC

group rickettsial infection to study the initial events in disease development. The most
appropriate strain of mouse was identified to be evaluated as a transmission model, and

M
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the course of infection, bacterial levels, histopathologic changes, and antibody response
during tick transmission in mice infested with Amblyomma maculatum ticks carrying the
emerging pathogen, Rickettia parkeri, were further studied. The results demonstrated
distinct clinical signs in C3H/HeN mice infected intravenously, leading to selection of

TE
D

this mouse strain for tick transmission studies. Active infection of animals was observed
after tick vector transmission. The bacteria disseminated systemically and had spread to
several organs at 24 hours post tick attachment (p.t.a.), with peak bacterial load at day

EP

6 p.t.a. Skin, lung, and liver showed the greatest pathologic changes with inflammatory
cellular infiltration and necrosis. These findings indicate the feasibility of using murine

AC
C

infection with R. parkeri by A. maculatum tick transmission as a model to study different
aspects of spotted fever group rickettsial disease establishment.
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Introduction
Several species of spotted fever group (SFG) Rickettsia infect animals and humans
worldwide. Severe disease is observed in humans exposed to ticks carrying Rickettsia

RI
PT

rickettsii and Rickettsia conorii. Rickettsial pathogens are prevalent in particular
geographic regions determined in large part by the vector. In the United States,
Rickettsia parkeri causes disease in humans after transmission primarily via

SC

Amblyomma maculatum ticks, but under experimental conditions, A. americanum can
also serve as a competent vector 1, 2. Rickettsia parkeri rickettsiosis was first described
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in 2004 as a human disease. Through June 2016, a total of 39 cases, predominantly
from the southeastern United States, has been documented in the scientific literature or
confirmed by laboratory assays at CDC 3, 4. However, the true incidence of R. parkeri
rickettsiosis in the United States is unknown. Serologic assays currently used to

TE
D

diagnose SFG rickettsial infections lack species-specificity because there is
considerable cross-reactivity among pathogens. It is likely that some of the
approximately 13,500 non-characterized cases of SFG rickettsioses reported in the

EP

United States during 2008 to 2012 were caused by R. parkeri 5. Rickettsia parkeri has
been incriminated as the most important pathogen of spotted fever rickettsiosis in

AC
C

Uruguay, Argentina, and parts of Brazil 6-9. With increasing incidence of these infections,
it is important to understand the potential for disease development and to study the
immune responses to SFG rickettsiae. Many animal models have been developed but
are incomplete due to limitations in the potential approaches to the host immune
system, or lacking the aspect of tick transmission in understading the pathogenesis of
these diseases. Needle-injected murine models of SFG rickettsial infections have been
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developed that mimic the various human pathologies observed during mild and severe
forms of the diseases. A murine model of R. parkeri infection using C3H/HeJ mice
demonstrates that a portion of intradermally inoculated mice developed eschar-like

RI
PT

necrotic lesions at the initial needle injection site that may be useful in understanding
aspects of the pathogenesis and immunology of a non-fatal SFG rickettsiosis 10.
C3H/HeN mice inoculated intravenously with R. conorii develop disseminated

SC

endothelial infection, become ill on day 4, and die on days 5 or 6 due to vascular injury–
based meningoencephalitis and interstitial pneumonia11. The C3H/HeN mouse strain
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provides the best model to date for examining rickettsial disease with endothelial
infection and injury 11. Rickettsia australis establishes a dose-dependent fatal infection
model in C57BL/6 (B6) mice 12 and, therefore, also provides a very useful tool for
mechanistic studies of both immunity to and pathogenesis of rickettsial diseases. As

TE
D

SFG rickettsiae are transmitted primarily via tick vectors, the role of tick saliva in the
dissemination and transmission of rickettsial agents is of considerable interest.
Intradermal inoculation of R. conorii into C3H/HeJ mice in the presence of saliva from

13

EP

Rhipicephalus sanguineus ticks inhibits the proinflammatory effects of IL-1β and NF-κB
. Additionally, intradermal needle inoculation of R. parkeri in the presence of

AC
C

uninfected feeding ticks results in significantly increased rickettsial loads in the organs
when compared with mice that are infected by intradermal needle inoculation of R.
parkeri without tick feeding 14. Additional work has provided preliminary data toward
development of an immunocompetent rhesus macaque model using intradermal
inoculation of R. parkeri during A. maculatum feeding with eschar formation and
increased inflammatory markers in serum 15. Guinea pig animal models have also been
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used to determine a few aspects of transmission and disease presentation 16, 17;
however, the guinea pig model has several significant limitations with respect to
investigations of the immune response and disease pathways in the vertebrate host due

RI
PT

to paucity of reagents for this species, lack of gene knockout animals, and paucity of
inbred animals for adaptive transfer experiments. Although many aspects of rickettsial
diseases have been studied using animal models, the complex interaction among the

SC

infected vector tick, the host and the pathogen has not been addressed experimentally
due to the absence of a tick transmission mouse model of SFG rickettsiosis that mimics
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naturally occuring infection that is essential for studing the natural events of immunity
and pathogenesis of these tick-borne diseases.

Materials and Methods

TE
D

Experimental design

Our experiments were performed in two completely separate phases. Because tick
transmission experiments are very elaborate to perform, the most susceptible mice

EP

strain to R. parkeri infection by needle inoculation was first determined. Thereafter, the
selected strain was used to evaluate tick-transmitted infection using A. maculatum

AC
C

carrying R. parkeri.

Phase 1: Identification of a suitable mouse strain for R. parkeri infection:
Bacteria/inoculum

Rickettsia parkeri (strain Maculatum 20 originally obtained from Chip Pretzman, Ohio
Department of Health) was maintained and amplified in cell culture using Vero cells.
Bacterial inoculum was prepared by sonication of highly infected cell culture, for
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pathogen release, followed by ultracentrifugation to concentrate the bacteria, and
further dilution to the desired inoculum dose 18. The concentration of viable rickettsiae
was determined by plaque assay as described in previous studies 19. Species identity

RI
PT

was confirmed by sequencing the sca5, htrA, and sca0 genes in the DNA extracted
from the infected cell culture and inoculum samples, in triplicate, using a 3130xl Genetic
Analyzer (Life Technologies, CA). The inoculum dose used for intravenous infection

SC

was determined to be approximately 1.2 x 107 bacteria/mouse.
Animals and infection

M
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Six- to eight-week–old female C57BL/6, BALB/c, and C3H/HeN mice (Envigo Inc., TX),
in groups of five animals (two as negative controls) per time point, were inoculated by
the intravenous (IV) route with R. parkeri or control medium, to identify the mouse strain
with greatest susceptibility to infection to be used for the tick transmission studies.

TE
D

Collection of samples

Samples of spleen, liver, lung, brain, heart, thymus, kidney, lymph nodes (brachial and
inguinal), and skin were collected from the needle-inoculated animals. Parts of all

EP

samples were fixed in 10% neutral buffered formalin for histopathology, and additional
parts of spleen, liver, lung, brain, and skin were obtained for determination of the

AC
C

bacterial burdens. Also, whole blood samples were obtained by cardiac puncture prior
to euthanasia for separation of serum to be used for titration of antibodies against R.
parkeri. For initial studies of the most appropriate mouse strain to be further used to
develop the tick transmission models, samples were collected during the acute infection
(day 6 p.i.) and after recovery at day 30 p.i. from IV infected C57Bl/6, C3H/HeN, and
Balb/c mice.

7
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Determination of bacterial loads
Samples of organs were processed for DNA extraction using DNeasy Blood & Tissue
Kit (Qiagen, Valencia, CA) with a few modifications. Detection and quantification of

RI
PT

rickettsial DNA were performed by targeting the citrate synthase gene (gltA) by real time
PCR using an iCycler IQ from Bio-Rad Laboratories (Hercules, CA), as described

previously 20, 21. Briefly, the rickettsial burdens were determined using the primers: gltA

SC

forward: 5’GAGAGAAAATTATATCCAAATGTTGAT3’ and gltA reverse:

5’AGGGTCTTCGTGCATTTCTT3’ (Sigma-Genosys, St. Louis, MO); and gltA probe:
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5’CATTGTGCCATCCAGCCTACGGT3’ (Biosearch Technologies, Novato, CA). The
results were normalized to the DNA concentration of the same sample, and expressed
as copy number of gltA rickettsial genes per microgram of DNA. Tissues from
uninfected mice served as negative controls.

TE
D

Histopathology

After formalin fixation, paraffin embedding, and sectioning, tissue samples were stained
with hematoxylin and eosin for microscopic evaluation and identification of pathological

EP

changes.

Determination of antibody titer by immunofluorescence assay

AC
C

The serum samples of mice infected by the IV route were assayed for IgG antibodies
against R. parkeri antigen by immunofluorescence assay (IFA). Vero cells infected with
R. parkeri and uninfected cell controls were coated on IFA slides and fixed in acetone.
Serum samples were added to the slides in serial two-fold dilutions. The titer of serumspecific antibody was evaluated by fluorescent microscopy, using positive (anti-SFGR
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antibody) and negative (naïve mouse serum) control samples and evaluation of

Phase 2: Development of tick transmission model:
Tick vector/Bacteria

RI
PT

rickettsial morphology in positive samples for specificity.

For the vector tick transmission studies, field-collected A. maculatum ticks naturally

SC

carrying R. parkeri (most closely related to Portsmouth strain) were generously provided
by Dr. Shahid Karim (University of Southern Mississippi, Hattiesburg, MS) 22, 23. The
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infected colony was established in 2014 (12% to 32% carrying R. parkeri 22, 24) and has
been maintained under laboratory conditions thereafter. The microbiome of the A.
maculatum did not reveal other pathogens besides R. parkeri as described in
Budachetri et al22. The analysis of sca0 gene sequences revealed 100% homology of

TE
D

Maculatum 20 strain, Portsmouth strain, and R. parkeri in A. maculatum ticks. Five to
nine nymphs of A. maculatum–carrying R. parkeri per mouse were used to study the
infection transmitted by ticks. The same number of uninfected A. maculatum nymphs

EP

was used to infest control animals.
Animals and infection

AC
C

Rickettsia parkeri infection following IV inoculation (details below) demonstrated that
C3H/HeN mice were the most suitable strain to use for development of an R. parkerivector tick transmission model of SFG rickettsiae as they developed the greatest
bacterial loads. After determining the mouse strain with the highest levels of infection
and greatest clinical signs, tick infestation was performed in groups of three mice, with
R. parkeri-carrying A. maculatum nymphs. Samples were collected at three pre-
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determined time points when the animals were euthanized to evaluate infection, disease
development, and pathologic lesions in comparison with mice infested with uninfected
ticks (groups of two animals per time point). A restrained feeding capsule was used to

RI
PT

locate the area of sample collection at the site of tick attachment.
Collection of samples

Tissue samples were collected as described in phase 1. For the development of the A.

SC

maculatum tick transmission model of R. parkeri infection, the samples were obtained
during the course of infection at 24 hours post tick attachment (p.t.a.) and days 6 and 12

M
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p.t.a. to evaluate the disease progression.

Bacterial load, histopathology, and antibody titer

The samples of tick-infested animals were processed for bacterial levels, histological
changes, and evaluation of antibody titers as described for phase 1.

TE
D

Immunohistochemistry (IHC)

Tissue sections were prepared for immunohistochemical detection of rickettsial antigen.
Samples were first deparaffinized, hydrated, and treated with proteinase K (Dako,

EP

Carpinteria, CA), for antigen retrieval. Then the sections were incubated with polyclonal
rabbit anti-spotted fever group rickettsial antibody at a dilution of 1:300 for one hour

AC
C

followed by biotinylated secondary goat anti-rabbit IgG antibody at 1:200 dilution (Vector
Laboratories, Burlingame, CA), streptavidin-AP (Thermo Scientific, Waltham, MA), and
Fast Red (Dako, Carpinteria, CA). The sections were counterstained with hematoxylin.
Naive rabbit serum was as employed as a negative primary antibody control.
Ethics Statement
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All experiments were performed in accordance with the guidelines of the Office of
Laboratory Animal Welfare and American Veterinary Medical Association, with approval
by the Institutional Animal Care and Use Committee of the University of Texas Medical

RI
PT

Branch at Galveston, Texas. OLAW - Animal Welfare Assurance A3314-

01.Amblyomma maculatum ticks were maintained at the University of Southern

Mississippi by a protocol approved by their Animal Care and Use Committee - Animal

M
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Results

SC

Welfare Assurance A3314-01.

Clinical and pathological effects of intravenous infection by R. parkeri in different
strains of mice (Phase 1)

Rickettsia parkeri induced subclinical infection even with a large infectious dose

TE
D

administered by the intravenous route in C57Bl/6 mice, which did not present any
clinical signs or behavioral changes during the course of infection. The evaluation of
bacterial levels during infection revealed low levels of copies of rickettsial gltA gene at

EP

day 6 p.i., as determined by real-time PCR. The lungs contained R. parkeri gltA DNA,
but the bacterial burden varied in other organs (Figure 1A). Evaluation of the

AC
C

histopathologic changes in tissues at this time point demonstrated extensive hepatic
lesions, with areas of coagulative necrosis surrounded by infiltration of macrophages,
lymphocytes, and PMNs (Figures 2A-B; 2D and E, respectively). Several areas of
inflammatory cellular infiltration consisting predominantly of perivascular lymphocytes
and macrophages, but also distributed throughout the tissue were also observed (Figure
2C). Numerous mitotic figures were present in all hepatic sections, suggesting a

11
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regenerative process. Infected C57Bl/6 mice also had mild interstitial pneumonia, foci of
peribronchovascular lymphocytic aggregates (Figure 2F), and focal lymphocytic
meningitis.

RI
PT

Late in the infection, at day 30 p.i., C57Bl/6 mice showed prominent granulation tissue
in liver tissue around the infarcts indicating tissue repair and accumulation of

lymphocytes around lung vessels and pulmonary bronchioles (Figures 2G-I). The anti-

SC

rickettsial antibody response of infected animals at this time point indicated a strong
induction of a host humoral immune response after IV rickettsial inoculation, with IFA

M
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titers of 1,024 or higher.

Balb/c mice infected by intravenous injection of R. parkeri showed only a mild decrease
in physical activity, but no other clinical manifestations. Similar to C57Bl/6 mice, they
contained low levels of rickettsial gltA gene copies at day 6 p.i. in the lungs, but with

TE
D

varied bacterial loads in other organs (Figure 1A). Also the histopathological changes
induced by Rickettsia parkeri infection in organs were similar to those observed in
C57Bl/6 mice, but less severe. Balb/c mice showed lower IgG titers than C57Bl/6 mice,

EP

around 512.

In contrast, C3H/HeN mice developed lethargy, mild hunched posture, ruffled fur, and

AC
C

decreased activity with onset around days 6 to 7 p.i. after IV infection. These clinical
manifestations persisted for two to three days until the animals recovered by day 9 or 10
p.i. These mice had bacterial DNA in all tissues evaluated at the time of clinical
manifestations of infection, with highest levels in the lungs. The peak of the rickettsial
burden in all organs tested was on day 6 p.i. Although the clinical signs of infection were
more prominent than in the other mouse strains, the infarcts in liver were less severe

12
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and cellular infiltration in lungs more diffuse, consistent with a reduced immune ability to
control the rickettsial infection (Figures 3A-E). The accumulation of lymphocytes was
also observed surrounding pulmonary blood vessels and airways (Figure 3F); however,

RI
PT

they were present less frequently in this mouse strain than in C57Bl/6 mice. The IgG
IFA titers were lower than the other strains, with levels around 256.

Evaluation of the results of the infection in mice inoculated IV with R. parkeri revealed

SC

that the C3H/HeN mice strain had the most severe clinical manifestations, highest

bacterial loads, and observed clinical disease course of the three mouse strains, with
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the best potential to be evaluated for development of a successful tick transmission
model.

Murine infection and clinical-pathological manifestations of Amblyomma

TE
D

maculatum tick-transmission of R. parkeri (Phase 2)

C3H/HeN mice were infested with the nymphal stage of A. maculatum carrying R.
parkeri. Clinical evaluation of animals infected by tick transmission revealed the

EP

development of illness between days 8 and 10 p.t.a., which represents a delay of
approximately two days of the clinical manifestations compared with mice infected with

AC
C

same rickettsial pathogen by the IV route. All animals showed a decrease in physical
activity, became less responsive to environmental stimuli, and progressed to more
severe clinical manifestations, including ruffled fur and hunched posture. Rickettsial
DNA was detected in the skin site of tick transmission at 24 to 36 hours p.t.a., and also
two of three animals already demonstrated early bacterial dissemination in tissues such
as lung and spleen at this time. During the peak of clinical illness, the quantity of

13
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bacteria in all tissues tested (spleen, liver, lung, and skin) also reached the highest
levels, including the tick bite site in the skin. At day 12 p.t.a. only two mice still
maintained rickettsial DNA detected by real-time PCR, one in liver and the other in the

RI
PT

skin site of tick feeding (Figure 1B). The skin was the only tissue that contained

rickettsial DNA in at least one animal at all time points evaluated throughout the course
of the experimental infection. The R. parkeri loads in tissues of animals infected by tick

SC

transmission were around 104 copies/µg of total DNA (Figure 1A and B). Initial foci of
inflammatory infiltration in liver tissue were observed as early as 24 to 36 hours
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following R. parkeri–carrying tick attachment, with frequent large foci containing
apoptotic cells surrounded by lymphocytes, macrophages, and PMNs (Figures 4A and
4B). Hepatic lesions at day 6 p.t.a. consisted of the presence of inflammatory foci with
distinct presence of PMNs (Figures 4H and 4I). Liver also contained areas of

TE
D

coagulative necrosis that were surrounded by inflammatory cells, mainly macrophages
(Figures 4F and 4G). The regenerative process was characterized in liver by the
presence of an increased number of hepatocytic mitotic figures throughout the tissue.

EP

Interestingly, at day 12 p.t.a., fewer inflammatory foci were identified in liver, and fewer
PMNs were observed compared to early infection. Peribronchial and perivascular

AC
C

infiltrations of lymphocytes and macrophages were also observed in the lungs of
infected animals at 24 to 36 hours p.t.a. (Figures 4C and 4D); larger foci were present at
day 6 p.t.a. (Figure 4E), , and small infiltrates were observed at 12 days p.t.a. Skin at
the tick feeding site showed inflammatory infiltration of mononuclear leukocytes and
numerous PMNs. Some of the tick feeding areas contained foci of necrotic epidermis
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and dermis typical of eschars, surrounded by inflammatory cellular infiltration observed
in infected mice at day 12 p.t.a. (Figures 4J to 4O).
Immunostaining revealed the presence of rickettsial antigen in some clearly identified

RI
PT

endothelial cells in brain, liver, and endocardium. Other cells also contained rickettsial
antigen during infection by tick transmission, potentially Kupffer cells, and splenic

macrophages. Interestingly, areas of massive presence of rickettsial antigen were

SC

observed in all the skin layers at 6 days p.t.a., within several cell types. Some areas of
inflammatory infiltration, especially in liver, surrounded rickettsiae-infected cells (Figure

M
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5).

Interestingly, mice infected with R. parkeri by A. maculatum tick transmission produced
an IFA IgG antibody response as early as day 12 p.t.a. at a titer of 512 or higher,

Discussion

TE
D

suggesting a strong humoral response.

Our experiments demonstrated a murine model of tick transmission of R. parkeri, an

EP

emerging SFG rickettsial pathogen with a broad distribution in the Western hemisphere.
With this model we will be able to study the complex tick-host-pathogen interface, and

AC
C

the effects on the host immune response and consequent disease development.
Recently, reports of R. parkeri infection were published showing an increase in human
cases of disease 3-5, 25-28. However, little is known about the disease establishment or
pathogenesis. Patients with R. parkeri disease remain moderately ill for seven to10
days with fever, vesicular or pustular rash (in approximately 40% of the patients), and
occurrence of eschar (around 90% of the patients) 25. Previous experiments have
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addressed developing animal models to evaluate R. parkeri infection; however, the
closest models to the natural transmission of infection used needle inoculation of
bacteria at the site of uninfected tick feeding. These studies have focused on the

RI
PT

generation of skin lesions by R. parkeri and the role of the tick feeding on development
of an eschar 14, 15. Interestingly, results obtained from these models revealed increased
PMNs in the skin site of infection when needle inoculation of rickettsiae was combined

SC

with tick feeding. The importance of tick feeding in enhancing infection by rickettsial
pathogens was also demonstrated in other studies, revealing R. parkeri interference
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with tick gene expression and suggesting the potential importance of the bacterial origin
from the vector for enhancement of transmission 22, 29, 30. Taken together these research
findings emphasize the importance of a natural model of infection with bacterial
passage through the tick vector before transmission to the skin of the vertebrate host by

TE
D

tick feeding.

Our findings revealed high bacterial loads after tick transmission demonstrated by
qPCR and immunostaining systemically, but even more intense in the skin site of tick

EP

feeding. Although endothelial cells were well characterized as the principal target cell
during systemic infection, as other researchers have shown, at the dermal area of

AC
C

transmission many cell types contained rickettsiae. This finding emphasizes the value of
sampling the skin inoculation site for the diagnosis of disease during the acute infection,
as observed in studies of eschar swabs from human patients with R. parkeri and other
SFG rickettsial infections. The skin site of experimental tick transmission showed
development of an eschar-like lesion, with necrotic dermis and epidermis and infiltration
of inflammatory cells into the area of tick feeding, similar to the described pathological
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changes in human cases of R. parkeri infection 31. The infection also induced
inflammatory infiltration in other infected organs during the course of illness.
Interestingly the prominent presence of PMNs and rickettsial antigen was observed in

RI
PT

skin and some of the affected organs, as occurs in human cases 25. The continuous
bacterial inoculation during the period of tick feeding would be technically challenging to
reproduce by needle inoculation as feeding takes many days. Increased infection levels

SC

in this model might have resulted from a higher inoculum by the arthropod, but it may
also result from a tick feeding effect on the host immune response favoring infection by

M
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the rickettsial pathogen. These results also demonstrate early induction of humoral
immunity occurring by 12 days after tick attachment.

This study demonstrated the development of a murine model of A. maculatum tick
vector transmission of SFG rickettsiae involving all aspects of the natural infection. The

TE
D

complexity associated with this natural model of tick transmission comprises: i) naturally
acquired rickettsial pathogen by the tick vector (transovarially maintained colony of
infected tick from nature); ii) horizontal transmission with bacterial dissemination within

EP

the tick and maintenance through the tick life stages (during colony maintenance); and
iii) transmission of the pathogen to the vertebrate host during prolonged tick feeding

AC
C

(presented in this manuscript). This model will be useful in evaluating the mechanisms
of rickettsial manipulation of the vector tick gene expression, rickettsial genes
expressed in the tick salivary glands and skin feeding site, and the effects of tick saliva
on the vertebrate host to induce infection and disease.
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Figures Legends
Figure 1 – Bacterial loads in tissues during rickettsial infection after intravenous
inoculations and by tick transmission. A: Levels of rickettsial citrate synthase gene
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copies in tissues at day 6 after intravenous infection by R. parkeri in different strains of
mice. B: Levels of rickettsial citrate synthase gene copies in tissues from C3H/HeN

SC

mice infected with R. parkeri by tick transmission on day 6 post tick attachment.

Figure 2 – Histopathology of tissues from C57Bl/6 mice infected with R. parkeri by

M
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intravenous inoculation. A and B: Extensive mononuclear inflammatory cells around
regions of hepatic coagulative necrosis (scale bar: A: 10µm; B: 5µm). C: Lymphocytic
infiltration in a portal triad (scale bar: 5µm). D: Scattered small lobular foci of
inflammatory cell accumulations in hepatic lobules (scale bar: 10µm). E: Hepatic
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massive inflammatory infiltration surrounds areas of necrosis and in perivascular
locations at day 6 p.i., in mice infected with R. parkeri by intravenous inoculation (scale
bar: 10µm). F: Perivascular-peribronchial inflammatory infiltration in lung of IV-infected
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mice at 6 d.p.i. (scale bar: 10µm). G: Foci of lymphocytic infiltration in perivascular area
in lungs of IV-infected mice at day 30 p.i. (scale bar: 5µm). H and I: Multiple lobular foci
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of mononuclear cell accumulations in the liver of convalescent mice at 30 d.p.i. (scale
bar: 5µm).

Figure 3 – Histopathology of tissues from C3H/HeN mice infected intravenously
with R. parkeri. A and B: Areas of infarction surrounded by granulation tissue and
inflammatory cells in liver at day 6 p.i. (scale bar: A: 10µm; B: 2µm). C and D:
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Inflammatory infiltration in hepatic tissue of animals at 6 d.p.i. (scale bar: C: 10µm; D:
2µm). E: Focus of lymphocytic inflammation in lung at day 6 p.i. (scale bar: 5µm). F:
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Persistence of inflammatory infiltration in lung at day 30 p.i. (scale bar: 5µm).

Figure 4 – Histopathologic lesions in tissues of mice infected with R. parkeri by
tick transmission. A and B: Foci of inflammatory cells and perivascular infiltration in

SC

liver at 24 hours p.t.a. (arrows; scale bar: 5µm). C and D: Foci of lymphocytic infiltration
in peribronchial – perivascular areas of the lung of mice infected by tick transmission
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observed at 24 hours p.t.a. (arrows; scale bar: C: 5µm; D: 10µm). E: Similar lesions in
lung of mice at 6 days p.t.a. (arrow; scale bar: 10µm). F and G: Areas of infarction
(arrows; scale bar: F: 2µm; G: 5µm). H: Inflammatory infiltration with apoptotic cells
(arrow; scale bar: 5µm – boxed: higher magnification of the apoptotic cell) and PMNs (I,
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arrows) in liver of mice at day 6 after infection with R. parkeri by tick transmission (scale
bar: 2µm). J, K, and L: Remarkable presence of PMNs (arrows) and other inflammatory
cells at the R. parkeri–carrying A. maculatum tick feeding site in the skin (tick mouth

EP

parts and cement insertion – arrowheads) at day 6 p.t.a. (scale bar: J:10µm; K: 2µm; L:
5µm). M, N, and O: Area of necrosis of dermis and epidermis at skin site of R. parkeri–
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carrying tick attachment and feeding at day 12 p.t.a. (arrows; scale bar: M and N: 10µm;
O: 5µm).

Figure 5 – Immunostochemistry of R. parkeri antigen in tissues from IV-infected
C3H/HeN mice and by tick transmission. A and B: Presence of rickettsiae in brain of
IV-infected mice at 6 d.p.i., revealing endothelial and perivascular rickettsial antigen
(scale bar: A: 20µm; B: 50µm; individual rickettsial antigen – boxed in A). C and D:
24
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Identification of rickettsial infection in lung of IV-infected mice (scale bar: 20µm;
individual rickettsial antigen – boxed in D). E: Lymph node axillary infected with
rickettsiae in IV-inoculated mice at 6 d.p.i. (scale bar: 100µm). F, G, H, and I: Skin area
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of tick transmission with massive presence of rickettsial antigen in many cell types at
day 6 p.t.a., including perivascular infection (scale bar: F: 100µm; G, H, and I: 20µm). J,
K, and L: Rickettsial antigen present within areas of inflammatory infiltration in liver
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during tick transmission (day 6 p.t.a.) (scale bar: J, K: 50µm; L: 20µm). M and N:
Infection of lungs with visualization of individual bacteria in the lungs of R. parkeri
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infection by tick transmission at day 6 p.t.a. (scale bar: 20µm). O: Draining axillary
lymph node related to the site of tick attachment on day 6 p.t.a., showing presence of
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rickettsial antigen (scale bar: 100µm).
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